We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
-7.4%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$5.38B
AUM Growth
-$480M
Cap. Flow
+$130M
Cap. Flow %
2.42%
Top 10 Hldgs %
41.73%
Holding
224
New
23
Increased
133
Reduced
36
Closed
13

Top Buys

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$23.8M
2
GKOS icon
Glaukos
GKOS
+$20.8M
3
ARVN icon
Arvinas
ARVN
+$19.8M
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$18.4M
5
PACB icon
Pacific Biosciences
PACB
+$13.3M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$72.6M
2
GILD icon
Gilead Sciences
GILD
+$33.8M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$23.2M
4
TDOC icon
Teladoc Health
TDOC
+$19.5M
5
AVDR
Avedro, Inc Common Stock
AVDR
+$15.8M

Sector Composition

Rank Sector Weight
1 Healthcare 94.28%
2 Industrials 0.53%
3 Technology 0.51%
4 Financials 0.07%
5 Consumer Discretionary 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNTA
151
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$648K 0.01%
+50,000
New +$604K
FAST icon
152
Fastenal
FAST
$53.7B
$630K 0.01%
38,598
+19,002
+97% +$296K
ADMS
153
DELISTED
Adamas Pharmaceuticals
ADMS
$593K 0.01%
+116,000
New +$716K
ALV icon
154
Autoliv
ALV
$8.63B
$536K 0.01%
6,800
+3,218
+90% +$229K
CBPO
155
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$515K 0.01%
4,500
+891
+25% +$88.6K
IBKR icon
156
Interactive Brokers
IBKR
$40.7B
$506K 0.01%
37,600
+14,572
+63% +$181K
SQM icon
157
Sociedad Química y Minera de Chile
SQM
$20B
$501K 0.01%
18,200
+11,210
+160% +$309K
ST icon
158
Sensata Technologies
ST
$6.7B
$496K 0.01%
9,900
+3,738
+61% +$177K
MTD icon
159
Mettler-Toledo International
MTD
$26.8B
$493K 0.01%
700
+225
+47% +$165K
VAR
160
DELISTED
Varian Medical Systems, Inc.
VAR
$488K 0.01%
4,100
+1,309
+47% +$156K
ENTG icon
161
Entegris
ENTG
$20B
$485K 0.01%
10,300
+1,594
+18% +$67.2K
KEX icon
162
Kirby Corp
KEX
$8B
$485K 0.01%
5,900
+1,626
+38% +$125K
BF.B icon
163
Brown-Forman Class B
BF.B
$12B
$477K 0.01%
7,600
+1,183
+18% +$69.1K
IPGP icon
164
IPG Photonics
IPGP
$3.98B
$475K 0.01%
3,500
+1,359
+63% +$180K
MTB icon
165
M&T Bank
MTB
$36.2B
$474K 0.01%
3,000
+1,269
+73% +$200K
WSO icon
166
Watsco Inc
WSO
$15.1B
$474K 0.01%
2,800
+807
+40% +$131K
MKL icon
167
Markel Group
MKL
$25B
$473K 0.01%
400
+121
+43% +$137K
EA icon
168
Electronic Arts
EA
$52.4B
$470K 0.01%
4,800
+1,700
+55% +$160K
DPZ icon
169
Domino's
DPZ
$11B
$465K 0.01%
1,900
+600
+46% +$149K
MCHP icon
170
Microchip Technology
MCHP
$43B
$465K 0.01%
10,000
+2,766
+38% +$125K
WAB icon
171
Wabtec
WAB
$51B
$460K 0.01%
6,400
+2,018
+46% +$144K
ADI icon
172
Analog Devices
ADI
$181B
$458K 0.01%
4,100
+1,127
+38% +$128K
TRMB icon
173
Trimble
TRMB
$12.2B
$454K 0.01%
11,700
+3,742
+47% +$151K
SWKS icon
174
Skyworks Solutions
SWKS
$9.11B
$452K 0.01%
5,700
+1,722
+43% +$137K
CL icon
175
Colgate-Palmolive
CL
$72.9B
$448K 0.01%
6,100
+1,449
+31% +$105K
5 6
7
8 9

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Bellevue Group's Q3 2019 Portfolio in Review

As of Q3 2019, Bellevue Group held 224 positions worth $5.38B, down 8.2% from $5.86B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Bellevue Group's Q3 2019 filing shows 23 new, 133 increased, 36 reduced and 13 closed positions. Its largest new stake was Arvinas: 806,403 shares worth $17.4M. The largest sale was Celgene Corp, an estimated $72.6M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 95% a quarter earlier, followed by Industrials and Technology.

  • Bellevue Group's largest Q3 2019 buy was Arvinas: 806,403 shares worth $17.4M.
  • Bellevue Group added most to Ionis Pharmaceuticals in Q3 2019, an estimated $23.8M increase.
  • Bellevue Group's biggest Q3 2019 reduction was Celgene Corp, cutting an estimated $72.6M.
  • Bellevue Group fully exited Avedro, Inc Common Stock in Q3 2019, selling an estimated $15.8M.
  • Bellevue Group's ten largest holdings make up 42% of its $5.38B portfolio in Q3 2019.
  • Bellevue Group opened 23 new positions and closed 13 in Q3 2019.
  • Bellevue Group's portfolio value fell 8.2% quarter-over-quarter to $5.38B.

Based on Bellevue Group's 13F filing for Q3 2019, filed 14 Nov 2019.